https://ift.tt/2IVHF6y

Ogivri is used to treat breast cancer and gastric cancer and Biocon has regulatory approval to sell it in more than 80 countries worldwide.

from Markets https://ift.tt/34JWvEa

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads